Wilmington Healthcare appoints new Head of Digital
January 26, 2021 |
Wilmington Healthcare, which provides data, insight and intelligence for pharma and medtech companies, has appointed Pfizer’s former UK Digital Marketing Manager, Mikko Figura, as Head of Digital.
In his new role, Mikko will develop and drive the strategy and execution of our clients’ intelligence-led and data-driven omni-channel programmes. These combine multiple channels, including OnMedica – an online community providing bitesize, evidence-based Continuing Professional Development (CPD) and other content for GPs and specialist doctors.
Mikko joins Wilmington Healthcare from the Brain Tumour Charity where, as Head of Digital, he led a team responsible for delivering digital marketing and communications plans across the organisation for income generation and to support service delivery.
Prior to that, he was UK Digital Marketing Manager for Pfizer, where he developed the digital strategy for its UK Rare Diseases Business Unit, which became one of the company’s most successful digital engagement ventures, with initiatives such as patient mobile apps, interactive digital detail aids for sales representatives, and a series of multichannel marketing campaigns.
He also led a team of cross functional stakeholders and external agencies to deliver a consumer-facing multichannel awareness campaign for a rare disease, winning a Pfizer global innovation award in the process.
Mikko has also held roles in digital marketing, customer acquisition, and supporter retention at organisations across a range of industries, including publishing, politics, and B2B service delivery.
Simon Grime, of Wilmington Healthcare, says: “We’re delighted to have Mikko on the team and, having worked in both the pharma and healthcare charity sectors, he brings a really valuable blend of digital marketing experience to his new post.
“He will be a fantastic addition to the company, where he will play a key role in shaping our intelligence-led omni-channel marketing strategy and helping our clients deliver the optimal mix of channels to complement their customer engagement strategies.”
Ends
This content was provided by Wilmington Healthcare
Company Details
Latest Content from Wilmington Healthcare
Wilmington Healthcare appoints new director to lead cloud-based healthcare customer intelligence tool
Paul Rowe to lead intelligence tool that allows Industry to gain the complete picture of their changing NHS customer base and employ precision planning to access target customers and markets.
LOOKING AHEAD: UNDERSTANDING THE NHS CUSTOMER’S PRIORITIES FOR 2022/23
The recently published operational planning guidance describes what the NHS needs to achieve this year. Wilmington Healthcare’s Oli Hudson explores some of its critical themes and what they mean for...
NAVIGATING 2022: THE FIVE CRITICAL SHIFTS PHARMA NEEDS TO EMBRACE
With a stormy outlook predicted for health and care, Wilmington Healthcare’s Oli Hudson looks at the five critical shifts that pharma should focus on as it navigates its way through...
CHANGING FACES: UNDERSTANDING THE KEY CUSTOMER CONTACT POINTS WITHIN THE ICS LANDSCAPE
As well as creating new structures, the reforms underway within the NHS will see a considerable movement of people and power across the new Integrated Care Systems. Wilmington Healthcare’s Victoria...
We must be candid about our use of healthcare data if we want to win back public trust
As the government announces a delay to a new GP data sharing initiative amid privacy concerns, Gareth Thomas, Managing Director of Wilmington Healthcare, explains why industry must move fast to...
Wilmington Healthcare appoints new Solutions Director
Kirsty Fryer has been promoted to the role of Solutions Director for Wilmington Healthcare
Understanding the role of provider collaboratives
Oli Hudson, Content Director at Wilmington Healthcare, takes a look at the new groups of providers that are expected to play a pivotal role in integrating care.
How does the government plan to reshape the NHS?
Oli Hudson, of Wilmington Healthcare, explores the government’s new white paper, which proposes key reforms for health and social care
Integrated NHS finances: what do they mean for High Cost Drugs?
Oli Hudson and Steve How, of Wilmington Healthcare, explore NHS England’s new system-level funding and its impact on prescribing for High Cost Drugs
Covid-19: how is it affecting prescribing patterns?
Oli Hudson, Content Director at Wilmington Healthcare, analyses prescribing data in three key disease areas